Clinical Trials
4 trialsNCT01068483 2020-12-08
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
Novartis
Phase 1 Completed
NCT01363232 2020-10-05
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Array BioPharma
Phase 1 Completed
NCT01289041 2019-05-30
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
Novartis
Phase 2 Completed
NCT01613677 2017-04-20
Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer
Novartis
Phase 2 Withdrawn